Career upgrade: Learn practical AI skills for better jobs and higher pay.
Level up
All Practice Exams

100+ Free AOBPa Pathology Practice Questions

Pass your AOBPa Pathology Certifying Examination exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
Historically high among AOA pathology residents Pass Rate
100+ Questions
100% Free
1 / 100
Question 1
Score: 0/0

Which cell surface marker confirms B-cell origin in flow cytometry of a lymphoma?

A
B
C
D
to track
2026 Statistics

Key Facts: AOBPa Pathology Exam

~$1,850

Initial Exam Fee

AOBPa 2024-2026

100 MCQs

Written Component

AOBPa AP blueprint

500/800

Scaled Passing Score

AOBPa scoring

~22%

GI — Largest Blueprint Area

AOBPa AP content outline

9 hours

Total Exam Time (3 sections)

AOBPa exam structure

3 years

AP Residency Required

AOA/ACGME training

The AOBPa Pathology boards are the AOA's certifying exam for osteopathic pathologists, structured as a three-part assessment (written + oral + practical) over ~9 hours. The written component is 100 single-best-answer MCQs scored on a 200-800 scaled metric with a 500 cut score. Top blueprint weights are GI (~22%), Dermatopathology (~13%), OB/GYN (~13%), and Breast (~12%) — together >60% of the written exam. Fees total ~$1,850 initial with $600 per failed section.

Sample AOBPa Pathology Practice Questions

Try these sample questions to test your AOBPa Pathology exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 58-year-old woman with chronic GERD has an endoscopic biopsy showing columnar epithelium with goblet cells in the distal esophagus. Which of the following best characterizes this lesion?
A.Reflux esophagitis with no metaplasia
B.Barrett esophagus (intestinal metaplasia)
C.Squamous papilloma
D.Eosinophilic esophagitis
Explanation: Goblet cells (mucin-containing) in a columnar-lined distal esophagus define Barrett esophagus, the intestinal metaplasia that predisposes to esophageal adenocarcinoma. Surveillance protocols are based on the degree of dysplasia.
2A colon biopsy from a patient with bloody diarrhea shows continuous mucosal inflammation extending from the rectum proximally, crypt abscesses, and no granulomas. The most likely diagnosis is:
A.Crohn disease
B.Ulcerative colitis
C.Ischemic colitis
D.Pseudomembranous colitis
Explanation: Ulcerative colitis classically shows continuous mucosal-limited inflammation starting at the rectum with crypt abscesses and no granulomas. The continuous distribution and absence of granulomas distinguishes it from Crohn disease.
3A breast biopsy shows nests of cells with low-grade nuclei, monomorphic appearance, and loss of E-cadherin expression by immunohistochemistry. Which diagnosis fits best?
A.Invasive ductal carcinoma, NOS
B.Invasive lobular carcinoma
C.Tubular carcinoma
D.Mucinous carcinoma
Explanation: Loss of E-cadherin and a discohesive single-file growth pattern define invasive lobular carcinoma. CDH1 gene alterations cause loss of E-cadherin and are the molecular hallmark.
4A prostate needle biopsy shows fused glands with poorly formed lumens. The pathologist assigns Gleason pattern 4 to all of the tumor. Per the 2014 ISUP/2016 WHO grade group system, this corresponds to:
A.Grade Group 1 (Gleason 3+3=6)
B.Grade Group 2 (Gleason 3+4=7)
C.Grade Group 3 (Gleason 4+3=7)
D.Grade Group 4 (Gleason 4+4=8)
Explanation: Pure pattern 4 (4+4=8) corresponds to Grade Group 4. The system: GG1 (3+3), GG2 (3+4), GG3 (4+3), GG4 (8 — includes 4+4, 3+5, 5+3), GG5 (9-10).
5A skin biopsy shows a melanocytic lesion with Breslow thickness 2.3 mm, ulceration, and 4 mitoses/mm^2. What is the most appropriate next step in management based on these findings?
A.Observation alone — risk is very low
B.Wide local excision with 1 cm margin only
C.Wide local excision with consideration of sentinel lymph node biopsy
D.Mohs micrographic surgery is the gold standard
Explanation: Melanomas >1 mm or thinner lesions with adverse features (ulceration, high mitotic rate) warrant wide local excision (1-2 cm margin depending on thickness) plus discussion of sentinel lymph node biopsy for staging.
6Cervical screening shows atypical glandular cells (AGC). The most appropriate workup includes:
A.Repeat Pap in 1 year
B.Colposcopy with endocervical curettage and endometrial sampling if age >=35 or risk factors
C.HPV testing only
D.Loop electrosurgical excision procedure immediately
Explanation: AGC is associated with high-grade cervical squamous/glandular lesions and endometrial pathology. Workup requires colposcopy with ECC plus endometrial sampling if age >=35 or risk factors (abnormal bleeding, obesity, anovulation).
7A patient with chronic hepatitis C develops a liver mass. Biopsy shows trabeculae of polygonal cells with eosinophilic cytoplasm, intracytoplasmic bile, and increased reticulin. The diagnosis is:
A.Cholangiocarcinoma
B.Hepatocellular carcinoma
C.Hepatic adenoma
D.Focal nodular hyperplasia
Explanation: Trabecular architecture, eosinophilic cytoplasm, bile production, and altered reticulin pattern are classic for hepatocellular carcinoma. Markers: HepPar1+, glypican-3+, arginase-1+, AFP elevated in 50-60%.
8Flow cytometry on a lymph node shows CD5+, CD23+, CD19+, CD20 dim+, and surface immunoglobulin dim+ B cells. The most likely diagnosis is:
A.Chronic lymphocytic leukemia / small lymphocytic lymphoma
B.Mantle cell lymphoma
C.Marginal zone lymphoma
D.Follicular lymphoma
Explanation: CLL/SLL immunophenotype is CD5+/CD23+/CD20 dim/sIg dim. Mantle cell lymphoma is CD5+/CD23- with cyclin D1+. This distinction is high-yield on the boards.
9A bone marrow biopsy shows hypercellular marrow (>=20% blasts) with Auer rods. Flow cytometry shows CD13+, CD33+, CD117+, MPO+ blasts. This is consistent with:
A.Acute lymphoblastic leukemia
B.Acute myeloid leukemia
C.Chronic myeloid leukemia
D.Myelodysplastic syndrome
Explanation: AML is defined by >=20% blasts (or recurrent genetic abnormality) with myeloid markers (CD13, CD33, CD117, MPO) and Auer rods. Specific subtypes (APL t(15;17), AML t(8;21), inv(16)) are diagnostic regardless of blast count.
10A patient develops fever and back pain during a red cell transfusion. Lab shows hemoglobinuria and a positive direct antiglobulin test. The most likely reaction is:
A.Febrile non-hemolytic transfusion reaction
B.Acute hemolytic transfusion reaction (ABO incompatibility)
C.TRALI
D.Delayed hemolytic transfusion reaction
Explanation: AHTR from ABO incompatibility presents with fever, back/flank pain, hemoglobinuria, and hypotension during transfusion. The DAT is positive and post-transfusion sample shows hemolysis. Stop transfusion, supportive care, and notify blood bank immediately.

About the AOBPa Pathology Exam

The AOBPa Pathology Certifying Examination validates expertise across anatomic pathology (surgical pathology, cytopathology, autopsy/forensic basics) and clinical pathology (hematopathology, chemistry, coagulation, microbiology, transfusion medicine, molecular diagnostics, and laboratory management). DO candidates must complete an AOA- or ACGME-accredited pathology residency. The full credentialing event combines a 4-hour 100-question written exam with separate oral and 100-item practical (slide/image) components, scaled 200-800 with a passing score of 500.

Questions

100 scored questions

Time Limit

4 hours written; ~9 hours total across written + oral + practical components

Passing Score

Scaled score >=500 on a 200-800 scale

Exam Fee

~$1,850 initial ($1,800 exam + $50 application); $600 per section for re-examination (American Osteopathic Board of Pathology (AOBPa) under the American Osteopathic Association (AOA))

AOBPa Pathology Exam Content Outline

~22%

Gastrointestinal & Hepatobiliary Pathology

Esophageal (Barrett, eosinophilic esophagitis, adenocarcinoma), gastric (H. pylori, GIST CD117/DOG1, intestinal-type vs diffuse adenocarcinoma), IBD UC vs Crohn (skip lesions, granulomas), colon polyps (TA vs TVA vs SSL, FAP, Lynch MLH1/MSH2/MSH6/PMS2), HCC vs cholangiocarcinoma, pancreatic IPMN/PanIN/PDAC, primary biliary cholangitis.

~25%

Breast, Gyn & GU Pathology

DCIS grades, invasive ductal vs lobular (E-cadherin), ER/PR/HER2 + Ki-67, Oncotype DX. Cervix HPV/LSIL/HSIL/AIS, endometrial EIN/endometrioid/serous, ovarian HGSC/LGSC/clear cell, placenta. Prostate Gleason/ISUP grade groups, urothelial CIS vs T1, RCC (clear cell/papillary/chromophobe), seminoma vs NSGCT.

~13%

Dermatopathology

Spongiotic vs psoriasiform vs lichenoid patterns, melanoma Breslow + ulceration + mitoses, dysplastic nevus, BCC vs SCC, Merkel cell, mycosis fungoides, dermatofibroma vs DFSP (CD34), neurofibroma vs schwannoma.

~10%

Head & Neck, Lung & Soft Tissue

Salivary pleomorphic adenoma vs adenoid cystic vs mucoepidermoid, thyroid PTC nuclear features/BRAF V600E, lung adenocarcinoma TTF-1/Napsin/EGFR/ALK/PD-L1, SCC p40/p63, SCLC, mesothelioma, soft tissue WHO categories, immunohistochemistry panels.

~10%

Hematopathology

Reactive vs neoplastic lymph node, DLBCL/FL/MCL/MZL/Burkitt, Hodgkin (cHL Reed-Sternberg CD15/CD30), plasma cell myeloma criteria, AML WHO/ICC, ALL (B vs T), CML BCR-ABL, CLL, MPN JAK2/CALR/MPL, MDS, flow cytometry interpretation.

~10%

Clinical Chemistry, Coag & Transfusion

Lipid panel, cardiac troponin, liver enzymes, AKI/CKD biomarkers, endocrine assays, TDM, intrinsic vs extrinsic coag pathway, DIC, factor deficiencies, lupus anticoagulant, ABO/Rh, antibody screen/identification, transfusion reactions (febrile, hemolytic, TRALI, TACO), apheresis.

~6%

Microbiology & Molecular Diagnostics

Gram stain interpretation, anaerobes, mycobacteria (AFB/Ziehl-Neelsen), fungal stains (GMS/PAS), parasitology, virology (HPV/HCV/HIV/CMV/SARS-CoV-2), MALDI-TOF, PCR, NGS solid tumor + heme panels, sensitivity testing, MIC interpretation.

~4%

Autopsy, Forensic & Lab Management

Cause vs manner of death, sudden cardiac death, perinatal/pediatric autopsy, postmortem interval, basic forensic toxicology. CAP/CLIA inspection prep, method validation (linearity, precision, accuracy), proficiency testing, Westgard rules, safety, ethics, billing/coding compliance.

How to Pass the AOBPa Pathology Exam

What You Need to Know

  • Passing score: Scaled score >=500 on a 200-800 scale
  • Exam length: 100 questions
  • Time limit: 4 hours written; ~9 hours total across written + oral + practical components
  • Exam fee: ~$1,850 initial ($1,800 exam + $50 application); $600 per section for re-examination

Keys to Passing

  • Complete 500+ practice questions
  • Score 80%+ consistently before scheduling
  • Focus on highest-weighted sections
  • Use our AI tutor for tough concepts

AOBPa Pathology Study Tips from Top Performers

1Master the GI blueprint first — at ~22% of the written exam it is the single highest-yield category. Drill IBD distinguishing features (UC: continuous, mucosal, crypt abscesses vs Crohn: skip lesions, transmural, non-caseating granulomas), polyp classification (TA, TVA, SSL with BRAF, HP), Lynch (MLH1/MSH2/MSH6/PMS2 IHC), GIST CD117/DOG1, gastric H. pylori, esophageal Barrett dysplasia grading, and pancreas IPMN vs PanIN vs PDAC.
2Internalize breast biomarker workflow: ER, PR, HER2 (IHC 0/1+/2+/3+, ISH for 2+), Ki-67. Know DCIS grade and necrosis criteria, invasive lobular E-cadherin loss, microinvasion definition (<=1 mm), and Oncotype DX/MammaPrint indications. For GU, ISUP grade groups (1: GS 3+3; 2: 3+4; 3: 4+3; 4: 8; 5: 9-10), prostate cribriform/intraductal pattern, and urothelial T1 vs CIS distinction are tested every cycle.
3Build a hematopathology framework by lineage: B-cell NHL (DLBCL CD20+, FL t(14;18), MCL t(11;14) cyclin D1, MZL, Burkitt c-MYC), T-cell, Hodgkin (cHL CD15+/CD30+ RS cells), plasma cell myeloma WHO criteria, AML (acute promyelocytic t(15;17), AML with t(8;21)), ALL B vs T, CML t(9;22) BCR-ABL, CLL flow (CD5+/CD23+/dim CD20). For MPN know JAK2 V617F (PV), CALR/MPL (ET/PMF).
4Drill transfusion and coagulation algorithms: ABO/Rh compatibility, antibody screen vs ID, transfusion reactions (febrile non-hemolytic, AHTR, TRALI vs TACO, anaphylactic IgA deficiency), massive transfusion 1:1:1 RBC:FFP:platelets, irradiation/CMV-safe/leukoreduction indications. Coag: PT vs aPTT mixing studies, factor deficiencies, DIC (low platelets, low fibrinogen, elevated D-dimer), lupus anticoagulant testing, heparin-induced thrombocytopenia (4Ts, SRA, serotonin release).
5Practice immunohistochemistry panels by tumor type: lung adeno (TTF-1+, Napsin A+, CK7+, p40-), SCC (p40+, p63+, CK5/6+), SCLC (TTF-1+, synaptophysin/chromogranin/INSM1+, low Ki-67 atypical), mesothelioma (calretinin, WT-1, CK5/6+), GI carcinoma (CK20+, CDX2+, CK7-), prostate (PSA, PSAP, AR, NKX3.1, AMACR/p63 basal layer), thyroid PTC (TTF-1+, thyroglobulin+, BRAF V600E). Memorize 'positive AND negative' panels for melanoma (S100, SOX10, HMB-45, Melan-A) vs SCC.
6Rehearse cytology Bethesda terminology cold: NILM, ASC-US (HPV reflex), ASC-H, LSIL, HSIL, AGC, AIS, SCC, adenocarcinoma. For non-gyn FNA know thyroid Bethesda I-VI, salivary Milan I-VI, pancreas, and lung small biopsies. For lab management, master CAP/CLIA inspection categories, proficiency testing rules, Westgard QC (1-2s, 1-3s, 2-2s, R-4s, 4-1s, 10x), method validation parameters (precision, accuracy, linearity, AMR/CRR), and turnaround time / critical value reporting compliance.

Frequently Asked Questions

Who is eligible for the AOBPa Pathology certifying exam?

Candidates must be DOs from a COCA-accredited osteopathic college (or MDs from LCME-accredited US/Canadian schools, or ECFMG-certified IMGs) who have completed one approved internship year plus three years of anatomic pathology residency (or four combined AP/CP). An unrestricted state/territorial/Canadian medical license and adherence to the AOA Code of Ethics are required. Program directors must attest to satisfactory training.

How is the AOBPa Anatomic Pathology exam structured?

The full certifying event has three components administered over one fall weekend: a 4-hour written exam with 100 multiple-choice questions, an oral examination, and a 4-hour practical (slide/image-based) exam with approximately 100 items. Total testing time is about 9 hours. Each section is scored separately on a 200-800 scaled metric with a passing score of 500.

What is the fee for the AOBPa Pathology exam?

Initial application + exam is $1,850 ($1,800 exam fee + $50 application). Late applications incur a 30% surcharge. Re-examination is $600 per failed section. Annual Osteopathic Continuous Certification (OCC) fees apply once you are certified. Confirm current fees on the AOBPa exam page.

What topics carry the most weight on the AOBPa Anatomic Pathology blueprint?

Gastrointestinal pathology (~22%) is the single largest category, followed by Dermatopathology (~13%), OB/GYN pathology (~13%), Breast (~12%), GU (~6%), Head & Neck (~5%), and Pulmonary (~5%). Clinical pathology elements (heme, chemistry, blood bank, micro, lab management) collectively contribute ~25% on combined-track items and dominate the CP/Laboratory Medicine certifying exam.

How long should I study for the AOBPa boards?

Most pathology residents report 400-600 dedicated hours over 6-10 months. A common split is ~30% surgical pathology (GI, breast, GYN, derm, GU), ~20% other subsites (H&N, lung, soft tissue), ~20% hematopathology + transfusion, ~15% clinical chemistry/coag/micro/molecular, and ~15% cytology, autopsy, and lab management. Daily slide review plus targeted MCQ practice are essential.

What scaled score do I need to pass the AOBPa exam?

Each section is scored on a 200-800 scaled metric, with a scaled score of 500 or higher required to pass each component (written, oral, and practical). Individual content-area scores are reported for diagnostic feedback only and do not affect pass/fail status. Failure of any section requires retake of that specific section at $600 per section.

Is the AOBPa exam still being offered for new certifications?

AOBPa announced that the legacy primary certification exams in Anatomic Pathology, Clinical Pathology/Laboratory Medicine, and Forensic Pathology had their final administrations in 2024. DOs now seeking initial pathology certification typically pursue the American Board of Pathology (ABPath) AP/CP pathway. Existing AOBPa diplomates continue to maintain certification through Osteopathic Continuous Certification (OCC) Components 1-4. Confirm current AOBPa policy directly.

Does the AOBPa exam emphasize osteopathic principles?

Unlike clinically intensive AOA specialty boards (e.g., family medicine, internal medicine, FP), pathology certifying exams focus on laboratory and diagnostic expertise rather than direct osteopathic manipulative treatment. A small portion of items may reference osteopathic philosophy and AOA-specific ethics, but the bulk of the exam mirrors mainstream pathology blueprints used by ABPath.